| Bioactivity | Tin(IV) mesoporphyrin IX dichloride (Stannsoporfin) is a heme oxygenase (HO) inhibitor being developed for the prevention of hyperbilirubinemia in infants at risk of developing jaundice, extracted from patent WO2011103196A1[1]. |
| Target | HO |
| Name | Tin(IV) mesoporphyrin IX dichloride |
| CAS | 106344-20-1 |
| Formula | C34H36Cl2N4O4Sn |
| Molar Mass | 754.29 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Benjamin Levinson, et al. Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin. US20080113955A1. |
Tin(IV) mesoporphyrin IX dichloride
CAS: 106344-20-1 F: C34H36Cl2N4O4Sn W: 754.29
Tin(IV) mesoporphyrin IX dichloride (Stannsoporfin) is a heme oxygenase (HO) inhibitor being developed for the preventio
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.